Real-world data in the era of immune checkpoint inhibitors

被引：0
|
作者：
Narita, Yukiya [1 ]
机构：
[1] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.428
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY5-5
引用
收藏
页码：S250 / S250
页数：1
相关论文
共 50 条
  • [1] Myositis with immune checkpoint inhibitors in a real-world setting
    Reactions Weekly, 2020, 1794 (1) : 11 - 11
  • [2] Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data
    Toribio-Garcia, Irene
    Olivares-Hernandez, Alejandro
    Miramontes-Gonzalez, Jose Pablo
    Dominguez, Luis Posado
    Garcia, Ana Martin
    Bachiller, Rocio Eiros
    Figuero-Perez, Luis
    Martinez, Maria Garijo
    Ruiz, Jonnathan Roldan
    Hernandez, Lorena Bellido
    Fonseca-Sanchez, Emilio
    Sanchez, Pedro Luis
    del Barco-Morillo, Edel
    CANCERS, 2023, 15 (17)
  • [3] A real-world data of Immune checkpoint inhibitors in solid tumors from India
    Noronha, Vanita
    Abraham, George
    Patil, Vijay
    Joshi, Amit
    Menon, Nandini
    Mahajan, Abhishek
    Janu, Amit
    Jain, Srushti
    Talreja, Vikas T.
    Kapoor, Akhil
    Singh, Gunjesh Kumar
    Khaddar, Satvik
    Gupta, Kushal
    Rathinasamy, Narmadha
    Srinivas, Sujay
    Agrawal, Amit
    Ventrapati, Pradeep
    Prabhash, Kumar
    CANCER MEDICINE, 2021, 10 (05): : 1525 - 1534
  • [4] EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN GLIOBLASTOMA FROM REAL-WORLD DATA ANALYSIS
    Stuhlmiller, Timothy
    Quinn, Jameson
    Awawda, Alaa
    Blondin, Nicolas
    Iwamoto, Fabio
    Nabors, Burt
    Redfern, Charles
    Wasserman, Asher
    Cole, Zachariah
    Shapiro, Mark
    Kesari, Santosh
    NEURO-ONCOLOGY, 2023, 25
  • [5] Immune checkpoint inhibitors in the treatment of pleural mesothelioma: insights from real-world data
    Masatoshi Kanayama
    Takehiko Manabe
    Katsuma Yoshimatsu
    Rintaro Oyama
    Hiroki Matsumiya
    Masataka Mori
    Masaru Takenaka
    Koji Kuroda
    Fumihiro Tanaka
    International Journal of Clinical Oncology, 2025, 30 (4) : 705 - 717
  • [6] Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient Data
    Lippenszky, Levente
    Mittendorf, Kathleen F.
    Kiss, Zoltan
    LeNoue-Newton, Michele L.
    Napan-Molina, Pablo
    Rahman, Protiva
    Ye, Cheng
    Laczi, Balazs
    Csernai, Eszter
    Jain, Neha M.
    Holt, Marilyn E.
    Maxwell, Christina N.
    Ball, Madeleine
    Ma, Yufang
    Mitchell, Margaret B.
    Johnson, Douglas B.
    Smith, David S.
    Park, Ben H.
    Micheel, Christine M.
    Fabbri, Daniel
    Wolber, Jan
    Osterman, Travis J.
    JCO CLINICAL CANCER INFORMATICS, 2024, 8
  • [7] Real-world safety experience with immune checkpoint inhibitors in Saudi Arabia
    Al Nuhait, Mohammed
    Bajnaid, Eshtyag
    Al Otaibi, Abdulmalik
    Al Shammari, Abdullah
    Al Awlah, Yousef
    SCIENCE PROGRESS, 2021, 104 (01)
  • [8] Cardiotoxicity Related to Immune Checkpoint Inhibitors: A Real-World Retrospective Analysis
    She, Jianqing
    Liu, Hui
    Wu, Haoyu
    Tuerhongjiang, Gulinigaer
    Zheng, Tao
    Bai, Ling
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [9] Immune Checkpoint Inhibitors for Nasopharyngeal Carcinoma in a Real-world Setting in Japan
    Manako, Tomomi
    Yasumatsu, Ryuji
    Nakano, Takafumi
    Matsuo, Mioko
    Takeuchi, Toranishin
    Taura, Masahiko
    Tamae, Akihiro
    Yamauchi, Moriyasu
    Masuda, Muneyuki
    Taguchi, Kenichi
    Nakagawa, Takashi
    IN VIVO, 2023, 37 (02): : 747 - 755
  • [10] Real-world impact of immune checkpoint inhibitors in metastatic uveal melanoma
    Bol, K. F.
    Ellebaek, E.
    Donia, M.
    Schmidt, H.
    Bastholt, L.
    Kiilgaard, J. F.
    Svane, I-M.
    ANNALS OF ONCOLOGY, 2019, 30 : 539 - 539
12345